Disease-driven T cell activation predicts immune responses to vaccination against melanoma

Cancer Immunity

Volumn 3, Issue , 2003, Pages 1-7

  Speiser, Daniel E ^a,c   Rimoldi, Donata ^b   Batard, Pascal ^a   Liénard, Danielle ^a   Lejeune, Ferdy ^a   Cerottini, Jean Charles ^b   Romero, Pedro ^a,b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c Hopital Orthopedique de la Suisse Romande   (Switzerland)

Author keywords

Cytotoxic T cells; Human; Immunological monitoring; Melan A peptide; Melanoma; Vaccination

Indexed keywords

CD28 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; HLA A2 ANTIGEN; INFLUENZA VACCINE; MELAN A; T LYMPHOCYTE ANTIGEN; TUMOR ANTIGEN; TUMOR VACCINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; IMMUNE RESPONSE; INFLUENZA VACCINATION; MELANOMA; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE ACTIVATION; TUMOR CELL DESTRUCTION;

EID: 3042541542     PISSN: 14249634     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Jäger D, Jäger E, Knuth A. Vaccination for malignant melanoma: recent developments. Oncology 2001;60: 1-7. (PMID: 11150901)
2. Marchand M, Brichard V, van Baren N, Coulie PG. Biological and clinical developments in melanoma vaccines. Expert Opin Biol Ther 2001;1: 497-510. (PMID: 11727521)
3. Wang E, Phan GQ, Marincola FM. T-cell-directed cancer vaccines: the melanoma model. Expert Opin Biol Ther 2001;1: 277-90. (PMID: 11727535)
4. Rosenberg SA. A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity 1999;10: 281-7. (PMID: 10204484)
5. Merkenschlager M, Beverley PC. Evidence for differential expression of CD45 isoforms by precursors for memory-dependent and independent cytotoxic responses: human CD8 memory CTLp selectively express CD45RO (UCHL1). Int Immunol 1989;1: 450-9. (PMID: 2562244)
6. Azuma M, Phillips JH, Lanier LL. CD28- T lymphocytes. Antigenic and functional properties. J Immunol 1993;150: 1147-59. (PMID: 8381831)
7. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999;401: 708-12. (PMID: 10537110)
8. Hamann D, Baars PA, Rep MH, Hooibrink B, Kerkhof-Garde SR, Klein MR, van Lier RA. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 1997;186: 1407-18. (PMID: 9348298)
9. Bell EB, Sparshott SM, Bunce C. CD4+ T-cell memory, CD45R subsets and the persistence of antigen - a unifying concept. Immunol Today 1998;19: 60-4. (PMID: 9509759)
10. Pittet MJ, Valmori D, Dunbar PR, Speiser DE, Liénard D, Lejeune F, Fleischhauer K, Cerundolo V, Cerottini JC, Romero P. High frequencies of naive Melan-A/MART-1-specific CD8+ T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J Exp Med 1999;190: 705-15. (PMID: 10477554)
11. Marchand M, Van Baren N, Weynants P, Brichard V, Dréno B, Tessier MH, Rankin E, Parmiani G, Arienti F, Humblet Y, Bourlond A, Vanwijck R, Liénard D, Beauduin M, Dietrich PY, Russo V, Kerger J, Masucci G, Jäger E, De Greve J, Atzpodien J, Brasseur F, Coulie PG, van der Bruggen P, Boon T. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer 1999;80: 219-30. (PMID: 9935203)
12. Speiser DE, Liénard D, Pittet MJ, Batard P, Guillaume P, Lejeune F, Cerottini JC, Romero P. In vivo activation of melanoma specific CD8+ T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cells. Eur J Immunol 2002;32: 731-41. (PMID: 11870617)
13. Dunbar PR, Smith CL, Chao D, Salio M, Shepherd D, Mirza F, Lipp M, Lanzavecchia A, Sallusto F, Evans A, Russell-Jones R, Harris AL, Cerundolo V. A shift in the phenotype of Melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response. J Immunol 2000;165: 6644-52. (PMID: 11086110)
14. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392: 245-52. (PMID: 9521319)
15. Lanzavecchia A, Sallusto F. Progressive differentiation and selection of the fittest in the immune response. Nat Rev Immunol 2002;2: 982-7. (PMID: 12461571)
16. Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG, Schoenberger SP. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 2003;421: 852-6. (PMID: 12594515)
17. Sun JC, Bevan MJ. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003;300: 339-42. (PMID: 12690202)
18. Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 2003;300: 337-9. (PMID: 12690201)
19. Bourgeois C, Rocha B, Tanchot C. A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory. Science 2002;297: 2060-3. (PMID: 12242444)
20. Valmori D, Dutoit V, Schnuriger V, Quiquerez AL, Pittet MJ, Guillaume P, Rubio-Godoy V, Walker PR, Rimoldi D, Lienard D, Cerottini JC, Romero P, Dietrich PY. Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity. J Immunol 2002;168: 4231-40. (PMID: 11937585)
21. D. Liénard et al. Manuscript in preparation.
22. Altman JD, Moss PAH, Goulder PJR, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996;274: 94-6. (PMID: 8810254)